Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through a Congressional hearing. (credit: CSPAN) A pharmaceutical company once owned by Martin Shkreli will pay up to $40 million in a settlement that will also finally end his infamous price-gouging scheme involving the antiparasitic drug Daraprim. The Federal Trade Commission and its state […]
